|
Volumn 61, Issue 10, 2005, Pages 1418-1425
|
Mutation of surface residues to promote crystallization of activated factor XI as a complex with benzamidine: An essential step for the iterative structure-based design of factor XI inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZAMIDINE;
BENZAMIDINE DERIVATIVE;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 11;
BLOOD CLOTTING FACTOR 11A;
COMPLEMENTARY DNA;
LIGAND;
PEPTIDE;
RECOMBINANT PROTEIN;
SERINE;
ARTICLE;
BINDING SITE;
CATALYSIS;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG ANTAGONISM;
ENZYME ACTIVE SITE;
GENETICS;
HUMAN;
HYDROGEN BOND;
IC 50;
MACROMOLECULE;
METABOLISM;
MUTAGENESIS;
MUTATION;
PICHIA;
PROTEIN BINDING;
PROTEIN CONFORMATION;
SITE DIRECTED MUTAGENESIS;
X RAY CRYSTALLOGRAPHY;
BENZAMIDINES;
BINDING SITES;
BLOOD COAGULATION FACTORS;
CATALYSIS;
CATALYTIC DOMAIN;
CRYSTALLOGRAPHY, X-RAY;
DNA, COMPLEMENTARY;
FACTOR XI;
FACTOR XIA;
HUMANS;
HYDROGEN BONDING;
INHIBITORY CONCENTRATION 50;
LIGANDS;
MACROMOLECULAR SUBSTANCES;
MODELS, MOLECULAR;
MUTAGENESIS;
MUTAGENESIS, SITE-DIRECTED;
MUTATION;
PEPTIDES;
PICHIA;
PROTEIN BINDING;
PROTEIN CONFORMATION;
RECOMBINANT PROTEINS;
SERINE;
|
EID: 32944481073
PISSN: 09074449
EISSN: 13990047
Source Type: Journal
DOI: 10.1107/S0907444905024340 Document Type: Article |
Times cited : (32)
|
References (23)
|